Product Information
RISPERDAL CONSTA 12.5 MG VIAL is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $318.0511 per EA under NDC 50458030911. Its NADAC has been published 653 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458030911
Classification
Brand
Dosage Form
KIT
Last Updated
1/2/2026
Approval Type
New Drug (NDA)
FDA Application
NDA021346On Market Since
10/29/2003
Price Statistics
The NADAC for RISPERDAL CONSTA 12.5 MG VIAL has been published 653 times since Nov 28, 2013, and over the history we have for it it has risen 124.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $318.0511 per EA |
|---|---|
| All-time high | $318.0511 (Jun 24, 2026) |
| All-time low | $141.8280 (Nov 28, 2013) |
| 52-week high | $318.0511 |
| 52-week low | $308.1200 |
| Median price | $243.1958 |
| Average price | $237.3464 |
| Largest weekly change | +6.9% (Jan 16, 2019) |
| Weeks tracked | 653 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISPERDAL CONSTA 12.5 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for RISPERDAL CONSTA 12.5 MG VIAL, manufactured by Janssen Pharmaceuticals Inc., is $318.0511 per EA (NDC 50458030911), effective Jun 24, 2026.
How has the price of RISPERDAL CONSTA 12.5 MG VIAL changed over time?
Over the history we have for it, the NADAC for RISPERDAL CONSTA 12.5 MG VIAL has risen 124.3%. It has been tracked across 653 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RISPERDAL CONSTA 12.5 MG VIAL?
Since Nov 28, 2013, the NADAC for RISPERDAL CONSTA 12.5 MG VIAL has ranged from a low of $141.8280 (Nov 28, 2013) to a high of $318.0511 (Jun 24, 2026), with a median of $243.1958 per EA.
Are there cheaper alternatives to RISPERDAL CONSTA 12.5 MG VIAL?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RISPERDAL CONSTA 12.5 MG VIAL, but none are currently priced below it.
Who manufactures RISPERDAL CONSTA 12.5 MG VIAL?
RISPERDAL CONSTA 12.5 MG VIAL (NDC 50458030911) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification